JP2025503646A5 - - Google Patents
Info
- Publication number
- JP2025503646A5 JP2025503646A5 JP2024541193A JP2024541193A JP2025503646A5 JP 2025503646 A5 JP2025503646 A5 JP 2025503646A5 JP 2024541193 A JP2024541193 A JP 2024541193A JP 2024541193 A JP2024541193 A JP 2024541193A JP 2025503646 A5 JP2025503646 A5 JP 2025503646A5
- Authority
- JP
- Japan
- Prior art keywords
- level
- pharmaceutical composition
- composition according
- patient
- dynorphin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298047P | 2022-01-10 | 2022-01-10 | |
| US63/298,047 | 2022-01-10 | ||
| PCT/IB2023/050170 WO2023131920A1 (en) | 2022-01-10 | 2023-01-09 | Compositions and methods for the treatment of depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503646A JP2025503646A (ja) | 2025-02-04 |
| JP2025503646A5 true JP2025503646A5 (https=) | 2026-01-16 |
Family
ID=84981555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541193A Pending JP2025503646A (ja) | 2022-01-10 | 2023-01-09 | うつ病の治療のための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250221960A1 (https=) |
| EP (1) | EP4463152A1 (https=) |
| JP (1) | JP2025503646A (https=) |
| KR (1) | KR20240132479A (https=) |
| CN (1) | CN118510507A (https=) |
| AU (1) | AU2023205471A1 (https=) |
| CA (1) | CA3247760A1 (https=) |
| IL (1) | IL314179A (https=) |
| MX (1) | MX2024008618A (https=) |
| WO (1) | WO2023131920A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024336807A1 (en) * | 2023-09-06 | 2026-04-16 | Janssen Pharmaceuticals, Inc. | Compositions comprising aticaprant for use in treating major depressive disorder |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009094260A1 (en) * | 2008-01-22 | 2009-07-30 | Eli Lilly And Company | Kappa selective opioid receptor antagonist |
-
2023
- 2023-01-09 JP JP2024541193A patent/JP2025503646A/ja active Pending
- 2023-01-09 KR KR1020247026164A patent/KR20240132479A/ko active Pending
- 2023-01-09 WO PCT/IB2023/050170 patent/WO2023131920A1/en not_active Ceased
- 2023-01-09 AU AU2023205471A patent/AU2023205471A1/en active Pending
- 2023-01-09 US US18/727,772 patent/US20250221960A1/en active Pending
- 2023-01-09 CN CN202380016647.0A patent/CN118510507A/zh active Pending
- 2023-01-09 EP EP23700339.7A patent/EP4463152A1/en active Pending
- 2023-01-09 IL IL314179A patent/IL314179A/en unknown
- 2023-01-09 CA CA3247760A patent/CA3247760A1/en active Pending
- 2023-01-09 MX MX2024008618A patent/MX2024008618A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021035955A (ja) | 多発性硬化症を処置するためのｓ１ｐ受容体モジュレーター | |
| BG108379A (bg) | Използване на енантиомерно чист есциталопрам | |
| Lee et al. | Sulfuretin, a major flavonoid isolated from Rhus verniciflua, ameliorates experimental arthritis in mice | |
| KR20060109493A (ko) | 비만을 치료하기 위한 조합 약물 치료 | |
| JP2023527542A5 (https=) | ||
| JP2022527482A5 (https=) | ||
| Wang et al. | Electroacupuncture pretreatment alleviates myocardial injury through regulating mitochondrial function | |
| JP2011529958A (ja) | 脳卒中または一過性脳虚血発作を予防するための薬物を調製するためのドロネダロンの使用 | |
| IL292612A (en) | Treatment methods using mtorc1 modulator | |
| BR0316057A (pt) | Métodos de tratar, controlar ou prevenir um câncer especìfico e uma doença associada com angiogênese indesejada e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo e com a terapia de radiação, terapia hormonal, terapia biológica ou imunoterapia em um paciente sofrendo de um câncer especìfico, composição farmacêutica e kit | |
| JP6794454B2 (ja) | ランピルナーゼおよび／またはアンフィナーゼを使用するウイルス性結膜炎の処置 | |
| JPWO2023054732A5 (https=) | ||
| JP2025503646A5 (https=) | ||
| KR20100135814A (ko) | 혈중 칼륨 수준의 조절을 위한 약제의 제조에 있어서의 드로네다론 또는 그의 제약상 허용가능한 염의 용도 | |
| JP2010530867A (ja) | うつ病の治療 | |
| JP2023510341A5 (ja) | ナルブフィン治療可能障害を治療するために投与されるナルブフィン製剤 | |
| IL315409A (en) | Polymorph forms of aticaprant for use in treating major depressive disorder | |
| TW200305570A (en) | Pharmaceutical composition for regeneration of cirrhotic liver | |
| JP2023538065A5 (https=) | ||
| Lee et al. | SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast‐like synoviocytes and mice with collagen‐induced arthritis | |
| WO2018163119A1 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| JP4226246B2 (ja) | 肝線維症および肝硬変の処置および予防のための薬剤組成物 | |
| IL314179A (en) | Compositions and methods for the treatment of depression | |
| TW200305424A (en) | Glaucoma-treating agent comprising bunazosin and prostaglandin | |
| JP2025503649A5 (https=) |